By Counterforce Health Team in Trikafta (elexacaftor/tezacaftor/ivacaftor) —

How to Get Trikafta Covered by Cigna in New York: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Trikafta Covered by Cigna in New York

Cigna requires prior authorization for Trikafta (elexacaftor/tezacaftor/ivacaftor) in New York. Approval depends on confirmed cystic fibrosis diagnosis with documented CFTR mutation (especially F508del), prescription by a CF specialist, and complete clinical documentation. If denied, New York's Department of Financial Services offers binding external appeals with strong overturn rates for CF medications when proper evidence is provided.

First steps today: 1) Confirm your CFTR genotype is documented, 2) Have your CF specialist submit the Cigna Trikafta PA form electronically, 3) Gather baseline lab results and prior therapy records.

Table of Contents

  1. Who Should Use This Guide
  2. Member & Plan Basics
  3. Clinical Criteria for Approval
  4. Coding Requirements
  5. Documentation Packet
  6. Submission Process
  7. Specialty Pharmacy Setup
  8. After Submission: What to Expect
  9. Common Denial Reasons & Solutions
  10. Appeals Process in New York
  11. FAQ
  12. Quick Reference Checklist

Who Should Use This Guide

This guide helps New York residents with Cigna insurance navigate Trikafta coverage, whether you're:

  • Starting Trikafta for the first time
  • Transferring from another insurer
  • Appealing a recent denial
  • Planning ahead before your prescription runs out

Expected outcome: With complete documentation, most patients with qualifying CFTR mutations get approved within 5 business days. If denied, New York's external appeal process has documented success overturning CF medication denials when clinical evidence supports medical necessity.

Member & Plan Basics

Coverage Verification

Before starting, confirm these basics through your myCigna account or member services (1-800-244-6224):

  • Active coverage with prescription benefits
  • Plan type (commercial, Medicare Advantage, or Medicaid managed care)
  • Specialty pharmacy requirement (most Cigna plans route Trikafta through Accredo)
  • Deductible status and specialty tier copay

Authorization Requirements

Cigna requires prior authorization for Trikafta across all plan types. The medication is typically placed on specialty formulary tiers with higher copays but no quantity limits once approved.

Clinical Criteria for Approval

Primary Requirements

Cigna's medical necessity criteria include:

  • Cystic fibrosis diagnosis confirmed by clinical presentation, family history, newborn screening, or elevated sweat chloride
  • Age 2 years or older at treatment initiation
  • CFTR genotype documentation showing at least one pathogenic or likely pathogenic mutation (F508del or one of 94 specified responsive mutations)
  • Specialist prescription by or in consultation with a physician specializing in CF care
  • Monotherapy use (cannot be combined with other CFTR modulators like Kalydeco or Symdeko)

No Step Therapy for F508del

Unlike some insurers, Cigna does not require step therapy for patients with F508del mutations. Direct coverage is available if clinical criteria are met. Step therapy may apply for certain non-F508del mutations where responsiveness data is limited.

Note: If your CFTR genotype is unknown, FDA-cleared mutation testing is required before coverage approval.

Coding Requirements

ICD-10 Diagnosis Codes

Use E84.0 (Cystic fibrosis with pulmonary manifestations) as the primary diagnosis code. This must appear on all prior authorization forms and medical necessity letters.

HCPCS/NDC Codes

Trikafta is an oral medication dispensed through specialty pharmacies, so standard NDC codes apply rather than medical benefit J-codes:

  • NDC: 78206-0150-28 (150mg/100mg/75mg tablets, 28-day supply)
  • Dosing: Two tablets in the morning, one tablet in the evening with fat-containing food

Documentation Packet

Medical Necessity Letter Components

Your CF specialist should include these elements in their letter:

Patient Information:

  • Full name, date of birth, Cigna member ID
  • Primary diagnosis: Cystic fibrosis (ICD-10: E84.0)

Clinical Justification:

  • CFTR genotype with specific mutation(s), laboratory name, and testing date
  • Current clinical status including FEV1 percentage, recent exacerbation frequency
  • Prior CFTR modulator use and outcomes (if applicable)
  • Treatment goals and expected benefits

Prescriber Qualification:

Required Attachments

  • CFTR genetic test results
  • Recent clinic notes with pulmonary function tests
  • Baseline liver function tests (AST, ALT, bilirubin)
  • Prior therapy documentation (if step therapy applies)

Submission Process

Electronic Submission (Preferred)

Submit through CoverMyMeds or SureScripts within your EHR system. Electronic submissions typically process faster and provide real-time status updates.

Alternative Methods

If electronic submission isn't available:

Processing Timeline

  • Standard review: Up to 5 business days
  • Expedited review: 72 hours for urgent medical needs
  • Ultra-expedited: 24 hours for urgent drug denials in life-threatening situations

Specialty Pharmacy Setup

Accredo Enrollment

Cigna routes Trikafta through Accredo specialty pharmacy. Once approved:

  1. Automatic transfer: Accredo will contact you to coordinate prescription transfer
  2. Direct enrollment: Call 877-826-7657 to initiate enrollment
  3. Required information: Insurance card, prescription, shipping address, payment method

Shipment Coordination

  • Delivery schedule: Monthly shipments with temperature-controlled packaging
  • Refill timing: Accredo typically ships 7-10 days before your current supply runs out
  • Backup planning: Request emergency supplies if traveling or experiencing delays

After Submission: What to Expect

Confirmation Process

  • Submission receipt: Electronic confirmations provide reference numbers
  • Status tracking: Monitor through myCigna portal or CoverMyMeds dashboard
  • Provider notification: Your CF team receives approval/denial notifications

Documentation Tracking

Keep records of:

  • Prior authorization reference number
  • Submission date and method
  • All supporting documents sent
  • Communication log with dates and representative names

Common Denial Reasons & Solutions

Denial Reason Solution Required Documentation
Missing CFTR genotype Submit FDA-cleared genetic test results Laboratory report with specific mutations
Incomplete clinical information Provide comprehensive medical necessity letter Current PFTs, clinical notes, treatment history
Prescriber specialty requirement Confirm CF specialist involvement Board certification documentation or consultation notes
Missing baseline labs Submit required safety monitoring results AST, ALT, bilirubin levels within 90 days
Administrative processing error Resubmit with complete PA form All required fields completed, legible signatures

Appeals Process in New York

Internal Appeals with Cigna

Timeline: Must file within 180 days of denial Process: Submit through member portal or call 1-800-244-6224 Documentation: Include denial letter, additional clinical evidence, updated medical necessity letter

New York External Appeals

If Cigna upholds the denial, New York's Department of Financial Services provides independent review:

Eligibility: Medical necessity denials, experimental/investigational determinations Filing deadline: 4 months after final adverse determination Cost: $25 fee (waived for financial hardship/Medicaid enrollees) Timeline:

  • Standard: 30 days
  • Expedited: 72 hours for urgent cases
  • Ultra-expedited: 24 hours for urgent drug denials

Success rates: Multiple documented overturns for CF medications when strong clinical evidence supports FDA-approved use and guideline recommendations.

Free Advocacy Support

  • Community Health Advocates: 888-614-5400 (free counseling for New York residents)
  • DFS Consumer Helpline: 1-800-342-3736

FAQ

How long does Cigna prior authorization take for Trikafta in New York? Standard review takes up to 5 business days. Expedited reviews for urgent cases are completed within 72 hours.

What if Trikafta isn't on my Cigna formulary? Request a formulary exception through the standard PA process. Include documentation showing no formulary alternatives are clinically appropriate for your CFTR genotype.

Can I get an expedited appeal in New York? Yes. If your health is at serious risk, both Cigna internal appeals and DFS external appeals offer expedited timelines (24-72 hours).

Does step therapy apply if I've used other CFTR modulators? For F508del mutations, Cigna typically doesn't require step therapy. Document any prior modulator use and clinical outcomes to support direct Trikafta approval.

What happens if I move from another state to New York? Your Cigna coverage continues, but you'll benefit from New York's stronger external appeal rights if coverage issues arise.

How much will Trikafta cost with Cigna in New York? Costs vary by plan tier. Specialty medications typically have higher copays ($50-$500/month), but manufacturer copay assistance and patient foundation programs may help reduce out-of-pocket costs.

Quick Reference Checklist

Before Starting:

  • Confirm active Cigna coverage with prescription benefits
  • Verify CFTR genotype documentation available
  • Identify CF specialist for prescription
  • Gather baseline lab results (liver function tests)

Submission Requirements:

  • Complete Cigna Trikafta PA form
  • Medical necessity letter from CF specialist
  • CFTR genetic test results
  • Recent clinic notes and pulmonary function tests
  • Baseline AST, ALT, bilirubin levels

After Submission:

  • Record PA reference number
  • Set up Accredo specialty pharmacy account
  • Monitor approval status through myCigna portal
  • Plan for monthly refill coordination

If Denied:

  • File internal appeal within 180 days
  • Gather additional clinical evidence
  • Consider DFS external appeal (4-month deadline)
  • Contact free advocacy resources if needed

About Counterforce Health

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals. Our platform analyzes denial letters and plan policies to create targeted, evidence-backed rebuttals that align with each payer's specific requirements. For complex cases like Trikafta coverage, we identify the exact clinical criteria and documentation needed to meet Cigna's medical necessity standards.

Whether you're facing a prior authorization challenge or planning ahead to prevent denials, Counterforce Health provides the tools and expertise to navigate insurance coverage successfully. Our payer-specific workflows and comprehensive evidence database help ensure your appeal includes the right citations, clinical facts, and procedural requirements for the best chance of approval.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Insurance coverage decisions depend on individual plan terms and medical circumstances. Always consult with your healthcare provider and insurance plan directly for coverage determinations. For free assistance with insurance appeals in New York, contact Community Health Advocates at 888-614-5400.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.